Karolinska Institutet, department of clinical neuroscience
Stockholm, Stockholm County, 17177, Sweden
NCT Number: NCT04826874
The overall aim of this project is to better understand the emotion regulating effect of labeling emotions (affecting labeling, AL) for individuals with self-perceived emotional regulation difficulties from both a clinical population and a non-clinical population, by using both self-assessment and psychophysiological testing of emotional activation. The main part of the project includes a brief intervention aiming to test the emotion-regulating effect of a short behavioral intervention to learn and practice AL. This two-week intervention, aims to improve the ability to regulate emotions, and to assess the benefits of emotion regulation strategies for individuals with and without a clinical diagnosis, but with self-perceived difficulties in emotion regulation.
The second part of this study aims to conceptually replicate a previous basic research study on AL and its emotion-regulating effect in a experimental laboratory setting and to extend that replication to include a clinical group. The replication contributes to an indepth understanding of AL as an implicit emotion regulation strategy in the short term, i.e. as a strategy used directly in the emotionally charged situation, and expands that knowledge to also include the effect in individuals with a clinical diagnosis. Also, it provides the opportunity to evaluate the effect of the two week AL behavioral intervention using psychophysiological testing.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stockholm, Stockholm County, 17177, Sweden
Main study: AFFECT LABELING - DAILY EXERCISE IN PUTTING WORDS ON EMOTIONS DESIGN AND PROCEDURE This clinical study is a randomized, wait-list controlled design with repeated measurements. Participants are randomized at inclusion between being directly offered a 14-day course to train AL and waiting two weeks before beginning the intervention. Participants are blind to this randomization and do not know that they are in the waitlist condition, in order to avoid nocebo effects. The randomization is done 1: 1, and stratified by clinical categorization (participants with or without a psychiatric diagnosis).
The course is given via a secure web platform (BASS4) in which the participant also makes all their assessments, and interacts with the study material and their course leader (clinical psychologist or master level psychology students).
Intervention - web course in affect labeling The intervention is given as a two week internet-delivered course in using AL with the guidance of a course leader (licensed psychologist or psychologist assistant under supervision). The course is divided into two modules where module 1 contains a) Psychoeducation about different emotions and its function, b) Information about AL and its potential emotion-regulating effect, c) Instruction on how to use AL in everyday life and d) Planning of daily short exercises in naming emotions. Daily registration with multiple choice answers is introduced to help the practice of AL. All assessments are web-based and reminders are sent to the participants' cellphone. The course leader is active in providing feedback on the exercises and planning.
Module 2 is largely a continuation of module 1 where any obstacles and other difficulties are discussed in order to increase the chance of active practice in AL, and continued daily practice. Module 3 is a brief summary of what has been taught and is made available to the participant after post-assessment.
Laboratory sub-study: Participants will also participate in a laboratory-based study where the emotion regulating effect of AL will be compared with distraction or passive viewing while being exposed to emotionally provocative visual stimuli. Participants are exposed to 3 blocks of 8 images and questions about the images ("trials") with equal numbers of negative and neutral valence in three conditions: instruction to "Watch", instruction to use AL and instruction to use Distraction. The instructions and pictures are given in a randomized, balanced order. Before each block, a 3-second instruction is displayed that indicates whether the participant should use "Watch", "AL" or "Distraction" for all 8 images in the block.
All participants will carry out the laboratory sub-study on two occasions: before and after the 14 day period it takes for the individuals who directly receives the web-based course in AL to complete it.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To be part of the clinical group, the participant must state a diagnosis established by a medical professional in the last 5 years, which involves clinical difficulties with emotion regulation such as binge eating disorder, emotional instability, generalized anxiety, depression, social anxiety or ADHD, and does not plan to start, change or discontinue any psychosocial or pharmacological treatment within the next 4 weeks. The non-clinical group must not have been diagnosed or treated for mental illness in the last 5 years.
Short behavioral intervention teaching affect labeling
Time frame: At day 1 and at day 14 (+/- 5 days)
Min 36, Max 180. Higher scores represents worse outcome
Time frame: At baseline and day 14 (+/- 5 days)
Min 0, Max 27. Higher scores represents worse outcome
Time frame: At baseline and day 14 (+/- 5 days)
Min 0, Max 21. Higher scores represents worse outcome
Time frame: At day 1 and day 14 (+/- 5 days)
Two sub scales: Cognitive reappraisal: Min 6 Max 42. Higher scores represents higher use of reappraisal. Suppression: Min 4 Max 28. Higher scores represents more use of suppression.
Time frame: At baseline and day 14 (+/- 5 days)
Min 20, Max 100. Higher scores represents worse outcome
Time frame: At baseline and day 14 (+/- 5 days)
Min 10 Max 40. Higher scores represents worse outcome
Time frame: At day 14 (+/- 5 days)
Min 8 Max 32 Higher scores represents better outcome
Time frame: At day 1 and day 14 (+/- 5 days)
9-degree Likert scale. Min 1 (Not upset at all) Max 9 (Very upset).
Time frame: 3*8*5 seconds at Day 1 and at Day 14 (+/-5 days)
changes in skin conductance, mean (micro-Siemens (μS)) between the different emotion regulation conditions
Time frame: At day 1 and at day 14 (+/- 5 days)
Heart Rate Variability is a measure which indicates the variation in your heartbeats within a specific timeframe.
Time frame: At day 1 and at day 14 (+/- 5 days)
Min 12, Max 60. Higher scores represents better outcome
Time frame: At day 1 and day 14 (+/- 5 days)
9-degree Likert scale. Min 1 (Not upset at all) Max 9 (Very upset).
Karolinska Institutet
Other
Acronym: AL_ER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07008209
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07337733
Alcohol Use Disorder, Alcohol-Related Disorders
Ajijic, Jalisco, Mexico
View Trial DetailsNCT01730261
Behavior, Brain Diseases
New York, United States
View Trial DetailsNCT07364799
Anxiety Disorders, Behavior
San Luis Obispo, California, United States
View Trial Details